135 related articles for article (PubMed ID: 11510761)
1. Effects of antihypertensive drugs and gene variants in the renin-angiotensin system.
Katsuya T; Iwashima Y; Sugimoto K; Motone M; Asai T; Fukuda M; Fu Y; Hatanaka Y; Ohishi M; Rakugi H; Higaki J; Ogihara T
Hypertens Res; 2001 Jul; 24(4):463-7. PubMed ID: 11510761
[TBL] [Abstract][Full Text] [Related]
2. Correlation of renin angiotensin system (RAS) candidate gene polymorphisms with response to Ramipril in patients with essential hypertension.
Gupta S; Chattopadhyaya I; Agrawal BK; Sehajpal PK; Goel RK
J Postgrad Med; 2015; 61(1):21-6. PubMed ID: 25511213
[TBL] [Abstract][Full Text] [Related]
3. Influence of renin angiotensin system gene polymorphisms on visit-to-visit blood pressure variability in hypertensive patients.
Kawai T; Ohishi M; Onishi M; Takeya Y; Ito N; Kato N; Yamamoto K; Kamide K; Rakugi H
Am J Hypertens; 2012 Dec; 25(12):1249-55. PubMed ID: 22932704
[TBL] [Abstract][Full Text] [Related]
4. Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes.
Dudley C; Keavney B; Casadei B; Conway J; Bird R; Ratcliffe P
J Hypertens; 1996 Feb; 14(2):259-62. PubMed ID: 8728305
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
Hannila-Handelberg T; Kontula KK; Paukku K; Lehtonen JY; Virtamo J; Tikkanen I; Hiltunen TP
J Hypertens; 2010 Apr; 28(4):771-9. PubMed ID: 20027122
[TBL] [Abstract][Full Text] [Related]
6. The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.
Goyache-Goñi B; Aranda-Lara P; Reyes-Engels A; Frutos-Sanz MA; Hernández-Marrero D
Nefrologia; 2013 Nov; 33(6):771-8. PubMed ID: 24241364
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension.
Giner V; Poch E; Bragulat E; Oriola J; González D; Coca A; De La Sierra A
Hypertension; 2000 Jan; 35(1 Pt 2):512-7. PubMed ID: 10642351
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations.
Baudin B
Pharmacogenomics; 2002 Jan; 3(1):65-73. PubMed ID: 11966404
[TBL] [Abstract][Full Text] [Related]
9. [Genetic polymorphisms of the renin-angiotensin system and essential hypertension].
Poch E; de La Sierra A; González-Núñez D; Oriola J; Redón J; Chaves FJ; Marín P; Giner V; Pamies E; Villar J; Ramírez R; Stiefel P; Rodríguez Pérez JC; Rodríguez Esparragón F; Martínez E; Carrión L; Sanchís C; Divisón JA;
Med Clin (Barc); 2002 Apr; 118(15):575-9. PubMed ID: 12015946
[TBL] [Abstract][Full Text] [Related]
10. Genetics of hypertension. Therapeutic implications.
O'Byrne S; Caulfield M
Drugs; 1998 Aug; 56(2):203-14. PubMed ID: 9711445
[TBL] [Abstract][Full Text] [Related]
11. RAS Genetic Variants in Interaction with ACE Inhibitors Drugs Influences Essential Hypertension Control.
Heidari F; Vasudevan R; Mohd Ali SZ; Ismail P; Arkani M
Arch Med Res; 2017 Jan; 48(1):88-95. PubMed ID: 28577874
[TBL] [Abstract][Full Text] [Related]
12. A common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older women.
Moraes CF; Souza ER; Souza VC; Medeiros EF; Gonçalves TF; Toledo JO; Karnikowski M; Gomes L; Karnikowski MG; Córdova C; Nóbrega OT
Clin Chim Acta; 2008 Oct; 396(1-2):70-5. PubMed ID: 18657531
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
14. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
16. [Genetic polymorphisms of the renin-angiotensin system and essential hypertension].
Fernández-Llama P; Poch E; Oriola J; Botey A; de la Sierra A; Revert L; Rivera F; Darnell A
Med Clin (Barc); 1999 May; 112(15):561-4. PubMed ID: 10365380
[TBL] [Abstract][Full Text] [Related]
17. Renin angiotensin system blockage associates with insertion/deletion polymorphism of angiotensin-converting enzyme in patients with hypertensive emergency.
Vilela-Martin JF; Vaz-de-Melo RO; Cosenso-Martin LN; Kuniyoshi CH; Yugar-Toledo JC; Pinhel MA; de Souza GF; Souza DR; Pimenta E; Moreno H; Cipullo JP
DNA Cell Biol; 2013 Sep; 32(9):541-8. PubMed ID: 23869738
[TBL] [Abstract][Full Text] [Related]
18. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
19. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes.
Thomas GN; Tomlinson B; Chan JC; Sanderson JE; Cockram CS; Critchley JA
Diabetes Care; 2001 Feb; 24(2):356-61. PubMed ID: 11213892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
